CAS No 76420-72-9 , Enalaprilat Search by region : Canada

Name: Enalaprilat
Synonyms: Vasotec IV; Enalapril acid;Enalaprilat; N-[(1S)-1-(Carboxy)-3-phenylpropyl]-L-alanyl]-L-proline Dihydrate; (2S)-1-[(2S)-2-[[(1S)-1-Carboxy-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid;ENALAPRILAT HYDRATE;(2S)-1-[(2S)-2-[[(1S)-1-Carboxy-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalaprilic Acid; ENALAPRILAT USP(CRM STANDARD);
CAS Registry Number:76420-72-9
Density: 1.286 g/cm3 (20 C)
EINECS: 278-459-3
Molecular Weight: 348.39
InChI: InChI=1/C18H24N2O5/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25)/t12-,14+,15+/m0/s1
Molecular Formula: C18H24N2O5
Molecular Structure:

Related products

Select to

          
           76420-72-9 ENALAPRILAT HYDRATE
           
             SynFine Research Inc.
             
              [Manufacturer]
Tel:  905-737-2702
Fax:  905-737-6299
Address: SynFine Research Inc. 
P.O. Box 433 ? Station A 
Richmond Hill, ON L4C 4Y8 
Canada null,nullCanada

           76420-72-9 ENALAPRILAT
           
             TLC PharmaChem., Inc.
             
              [Manufacturer]
Tel:  905-760-1098
Fax:  905-760-2098
Address: TLC PharmaChem., Inc.
5-150 Connie Crescent
Concord, Ontario
L4K 1L9, Canada null,nullCanada

           76420-72-9 ENALAPRILAT
           
             Synth?se AptoChem Inc.
             
              [Manufacturer]
Tel:  514-496-4252
Fax:  514-496-4253
Address: Synth?se AptoChem Inc.
6100 Royalmount Ave
Montreal, QC
Canada
H4P 2R2 null,nullCanada

Select to

1/1

References of Enalaprilat

Title: Enalaprilat
CAS Registry Number: 76420-72-9
CAS Name: N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl-L-proline dihydrate
Synonyms: enalaprilic acid
Manufacturers' Codes: MK-422
Trademarks: Vasotec IV (Merck & Co.)
Molecular Formula: C18H24N2O5.2H2O
Molecular Weight: 384.42
Percent Composition: C 56.24%, H 7.34%, N 7.29%, O 29.13%
Literature References: Nonsulfhydryl dipeptide angiotensin converting enzyme (ACE) inhibitor. Prepn: A. A. Patchett et al., Nature 288, 280 (1980); eidem, EP 12401; E. E. Harris et al., US 4374829 (1980, 1983 both to Merck & Co.). Active metabolite of enalapril, q.v.: D. J. Tocco et al., Drug Metab. Dispos. 10, 15 (1982). Pharmacology: D. M. Gross et al., J. Pharmacol. Exp. Ther. 216, 552 (1981); M. A. Nelson et al., Clin. Exp. Pharmacol. Physiol. Suppl. 7, 87 (1982); T. A. Unger et al., Biochem. Pharmacol. 31, 3063 (1982). Bioavailability: M. L. Cohen et al., J. Pharmacol. Exp. Ther. 226, 192 (1983). Kinetics of enzyme inhibition: C. H. Reynolds, Biochem. Pharmacol. 33, 1273 (1984). Pharmacokinetics: K. S. Pang et al., Drug Metab. Dispos. 12, 309 (1984). Acute hemodynamic effects in essential hypertension: A. C. Simon et al., Clin. Pharm. Ther. 43, 49 (1988). Clinical evaluation in severe and malignant hypertension: D. J. DiPette et al., ibid. 38, 199 (1985).
Properties: Needles from H2O, mp 148-151°. [a]D -67.0° (0.1M HCl).
Melting point: mp 148-151°
Optical Rotation: [a]D -67.0° (0.1M HCl)
Therap-Cat: Antihypertensive.
Keywords: ACE-Inhibitor; Antihypertensive; N-Carboxyalkyl (peptide/lactam) Derivatives.